Abbott Laboratories
People also watch:ABBVBMYLLYJNJMRK
43.410.24 (0.56%)

After hours: 43.410.00 (0.00%) as of 6:29 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close43.17
Bid43.00 x 100
Ask43.41 x 200
52wk Range36.00 - 51.24
Day's Range43.03 - 43.44
Avg Vol (3m)11,535,365
As of 4:03 PM EDT. Market closed.
  • American City Business Journals9 hours ago

    Massachusetts class-action lawsuit filed over Alere's blood test

    Adding to a lengthy list of problems faced by Waltham-based diagnostics firm Alere as it aims to complete its merger with Abbott came one more late last week: A new class-action lawsuit over a home blood coagulation test that was recalled over concerns of ita accuracy. The lawsuit is similar to one filed in California last month, according to John Roddy, a partner in the Boston offices of Alabama-based law firm Bailey & Glasser LLP, which filed the latest class-action lawsuit against Alere on Friday in federal court in Boston. Both address problems with the INRatio home blood test sold by Alere (ALR), used by patients who take blood thinners to determine the optimum size of dose needed for treatment.

  • Market Realist14 hours ago

    Abbott Laboratories Avoids a ‘Sell’ Rating from Analysts

    On July 20, 2016, Morgan Stanley gave Abbott Laboratories a one-year target price of $45, the lowest target price.